Location: Toronto, Ontario, Canada
CIK: 0001622627 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 12, 2026
Total Value: $285M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DCTH | DELCATH SYSTEMS, INC. | 3,300,389 | $33M | 11.6% | $6.89 | +44.3% | COM NEW | 24661P807 |
| SVRA | SAVARA INC | 3,403,721 | $20.52M | 7.2% | $3.31 | +48.0% | COM | 805111101 |
| FENC | FENNEC PHARMACEUTICALS INC | 2,613,508 | $20.12M | 7.1% | $6.23 | +31.7% | COM | 31447P100 |
| XERS | XERIS BIOPHARMA HOLDGS INC | 2,111,700 | $16.58M | 5.8% | $2.76 | +185.1% | COM | 98422E103 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 450,000 | $14M | 4.9% | $16.51 | +66.1% | COM | 92790C104 |
| MDWD | MEDIWOUND LTD | 749,054 | $13.83M | 4.9% | $14.40 | +26.9% | SHS NEW | M68830112 |
| VSTM | VERASTEM INC | 1,788,475 | $13.81M | 4.9% | $5.37 | +65.9% | COM NEW | 92337C203 |
| REPL | REPLIMUNE GROUP INC | 1,410,497 | $13.71M | 4.8% | $8.50 | 0.0% | COM | 76029N106 |
| ATYR | ASTRIA THERAPEUTICS INC | 1,039,080 | $13.6M | 4.8% | $4.53 | -81.9% | COM | 002120202 |
| HELP | CYBIN INC | 1,657,540 | $13.56M | 4.8% | $8.53 | -24.5% | COM NEW | 23256X407 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 690,000 | $12.61M | 4.4% | $11.67 | +21.5% | COM NEW | 30233G209 |
| CGON | CG ONCOLOGY INC | 300,000 | $12.46M | 4.4% | $25.87 | +59.9% | COM | 156944100 |
| CYTK | CYTOKINETICS INC | 195,045 | $12.39M | 4.4% | $34.78 | +78.8% | COM NEW | 23282W605 |
| XFOR | X4 PHARMACEUTICALS INC | 2,605,920 | $10.42M | 3.7% | $3.01 | +20.8% | COM NEW | 98420X202 |
| — | MIND MEDICINE MINDMED INC | 750,000 | $10.04M | 3.5% | $8.46 | — | COM NEW | 60255C885 |
| PROF | PROFOUND MEDICAL CORP | 1,068,955 | $8.413M | 3.0% | $8.06 | -20.3% | COM NEW | 74319B502 |
| NSPR | INSPIREMD INC | 3,905,743 | $6.952M | 2.4% | $2.46 | -15.4% | COM | 45779A846 |
| OCUL | Ocular Therapeutix, Inc | 400,000 | $4.856M | 1.7% | $7.23 | +68.0% | COM | 67576A100 |
| AVBP | ARRIVENT BIOPHARMA INC | 215,871 | $4.343M | 1.5% | $20.82 | 0.0% | COM | 04272N102 |
| TLPH | TALPHERA INC | 3,579,273 | $4.08M | 1.4% | $0.60 | +101.8% | COM NEW | 00444T209 |
| MYO | MYOMO INC | 3,839,772 | $3.494M | 1.2% | $3.08 | -68.9% | COM NEW | 62857J201 |
| — | INVESCO QQQ TR | 450,000 | $3.029M | 1.1% | — | — | Put | 46090E953 |
| PYPD | POLYPID LTD | 696,556 | $3.023M | 1.1% | $4.49 | -17.2% | COM | M8001Q126 |
| OKUR | ONKURE THERAPEUTICS INC | 730,488 | $2.118M | 0.7% | $2.99 | 0.0% | COM CL A | 68277Q105 |
| — | SPDR S&P 500 ETF TR | 510,000 | $1.886M | 0.7% | — | — | Put | 78462F953 |
| — | ANAVEX LIFE SCIENCES CORP | 1,168,600 | $1.881M | 0.7% | — | — | Put | 032797950 |
| RGNT | REGENTIS BIOMATERIALS LTD | 251,510 | $1.695M | 0.6% | $6.86 | 0.0% | ORDINARY SHARES | M8211G108 |
| — | SPDR SERIES TRUST | 1,937,600 | $1.348M | 0.5% | — | — | Put | 78464A950 |
| TRVI | TREVI THERAPEUTICS INC | 100,000 | $1.252M | 0.4% | $2.31 | +400.6% | COM | 89532M101 |
| — | ISHARES TR | 200,000 | $1.112M | 0.4% | — | — | Put | 464287955 |
| NRXS | NEURAXIS INC | 286,138 | $1.039M | 0.4% | $2.99 | 0.0% | COM | 64134X201 |
| KURA | KURA ONCOLOGY INC | 100,000 | $1.039M | 0.4% | $7.79 | +34.6% | COM | 50127T109 |
| GUTS | FRACTYL HEALTH INC | 385,731 | $849K | 0.3% | $1.30 | +24.1% | COM | 35168W103 |
| BFRI | BIOFRONTERA INC | 1,140,764 | $650K | 0.2% | $1.02 | -11.4% | COM NEW | 09077D209 |
| — | ARRIVENT BIOPHARMA INC | 107,900 | $540K | 0.2% | — | — | Call | 04272N902 |
| — | VERASTEM INC | 268,600 | $160K | 0.1% | — | — | Call | 92337C903 |
| — | UNIQURE NV | 100,000 | $95,000 | 0.0% | — | — | Call | N90064901 |
| — | REPLIMUNE GROUP INC | 230,900 | $11,545 | 0.0% | — | — | Call | 76029N906 |
| — | VIKING THERAPEUTICS INC | 100,000 | $2,000 | 0.0% | — | — | Call | 92686J906 |
| — | REPLIMUNE GROUP INC | 264,700 | $0 | 0.0% | — | — | Put | 76029N956 |
| — | VISTAGEN THERAPEUTICS INC | 493,400 | $0 | 0.0% | — | — | Call | 92840H900 |
| — | REZOLUTE INC | 263,100 | $0 | 0.0% | — | — | Call | 76200L909 |